{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:21:19Z","timestamp":1790216479631,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00428-025-04133-2","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T11:30:24Z","timestamp":1748604624000},"page":"1091-1102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Expanding the histologic spectrum of thyroid neoplasms with NTRK1\/2\/3 or ALK translocation: a single-center retrospective study of 82 cases"],"prefix":"10.1007","volume":"487","author":[{"given":"Ronald","family":"Ghossein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Instrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snjezana","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Chongtham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Mullaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibisha","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Shaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Michael","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Ganly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4638-9835","authenticated-orcid":false,"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"4133_CR1","unstructured":"(2024) WHO Classification of Tumours Editorial Board. WHO classification of tumours of endocrine and neuroendocrine tumours. https:\/\/tumourclassification.iarc.who.int\/chapters\/53. Accessed 12\/3\/2024 2024"},{"key":"4133_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1530\/EJE-17-0499","volume":"178","author":"AU Bastos","year":"2018","unstructured":"Bastos AU, de Jesus AC, Cerutti JM (2018) ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult population. Eur J Endocrinol 178:83\u201391. https:\/\/doi.org\/10.1530\/EJE-17-0499","journal-title":"Eur J Endocrinol"},{"key":"4133_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","volume":"17","author":"DT Cheng","year":"2015","unstructured":"Cheng DT, Mitchell TN, Zehir A, Shah RH, Benayed R, Syed A, Chandramohan R, Liu ZY, Won HH, Scott SN, Brannon AR, O\u2019Reilly C, Sadowska J, Casanova J, Yannes A, Hechtman JF, Yao J, Song W, Ross DS, Oultache A, Dogan S, Borsu L, Hameed M, Nafa K, Arcila ME, Ladanyi M, Berger MF (2015) Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J Mol Diagn 17:251\u2013264. https:\/\/doi.org\/10.1016\/j.jmoldx.2014.12.006","journal-title":"J Mol Diagn"},{"key":"4133_CR4","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/PAS.0000000000000368","volume":"39","author":"A Chou","year":"2015","unstructured":"Chou A, Fraser S, Toon CW, Clarkson A, Sioson L, Farzin M, Cussigh C, Aniss A, O\u2019Neill C, Watson N, Clifton-Bligh RJ, Learoyd DL, Robinson BG, Selinger CI, Delbridge LW, Sidhu SB, O\u2019Toole SA, Sywak M, Gill AJ (2015) A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma. Am J Surg Pathol 39:652\u2013659. https:\/\/doi.org\/10.1097\/PAS.0000000000000368","journal-title":"Am J Surg Pathol"},{"key":"4133_CR5","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/s41379-020-0574-4","volume":"33","author":"YH Chu","year":"2020","unstructured":"Chu YH, Dias-Santagata D, Farahani AA, Boyraz B, Faquin WC, Nos\u00e9 V, Sadow PM (2020) Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC). Mod Pathol 33:2186\u20132197. https:\/\/doi.org\/10.1038\/s41379-020-0574-4","journal-title":"Mod Pathol"},{"key":"4133_CR6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/modpathol.2016.115","volume":"29","author":"S Dogan","year":"2016","unstructured":"Dogan S, Wang L, Ptashkin RN, Dawson RR, Shah JP, Sherman EJ, Michael Tuttle R, Fagin JA, Klimstra DS, Katabi N, Ghossein RA (2016) Mammary analog secretory carcinoma of the thyroid gland: a primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion. Mod Pathol 29:985\u2013995. https:\/\/doi.org\/10.1038\/modpathol.2016.115","journal-title":"Mod Pathol"},{"key":"4133_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.21037\/atm-22-945","volume":"10","author":"L Du","year":"2022","unstructured":"Du L, Zhao Q, Li J, Wang M, Qiao H (2022) Expression of colorectal neoplasia differentially expressed in anaplastic thyroid carcinoma and its effect on cancer cell proliferation. Ann Transl Med 10:473. https:\/\/doi.org\/10.21037\/atm-22-945","journal-title":"Ann Transl Med"},{"key":"4133_CR8","doi-asserted-by":"publisher","first-page":"bvae158","DOI":"10.1210\/jendso\/bvae158","volume":"8","author":"O Elghawy","year":"2024","unstructured":"Elghawy O, Barsouk A, Heidlauf A, Chen S, Cohen RB, Sun L (2024) Single-institution experience of larotrectinib therapy for patients with NTRK fusion-positive thyroid carcinoma. J Endocr Soc 8:bvae158. https:\/\/doi.org\/10.1210\/jendso\/bvae158","journal-title":"J Endocr Soc"},{"key":"4133_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/pas.0000000000002371","volume":"49","author":"RA Ghossein","year":"2025","unstructured":"Ghossein RA, Scholfield DW, Qin H, Shaha AR, Ganly I, Xu B (2025) High-grade papillary thyroid carcinoma, diffuse sclerosing subtype: a series of 18 cases detailing the pathologic features, potential for misdiagnosis, and aggressive clinical behavior. Am J Surg Pathol 49:481\u2013489. https:\/\/doi.org\/10.1097\/pas.0000000000002371","journal-title":"Am J Surg Pathol"},{"key":"4133_CR10","doi-asserted-by":"publisher","first-page":"100222","DOI":"10.1016\/j.modpat.2023.100222","volume":"36","author":"JF Hang","year":"2023","unstructured":"Hang JF, Lee YC (2023) How sensitive is Pan-TRK immunohistochemistry for detecting NTRK fusions in papillary thyroid carcinoma? Mod Pathol 36:100222. https:\/\/doi.org\/10.1016\/j.modpat.2023.100222","journal-title":"Mod Pathol"},{"key":"4133_CR11","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/s1470-2045(19)30856-3","volume":"21","author":"DS Hong","year":"2020","unstructured":"Hong DS, DuBois SG, Kummar S, Farago AF, Albert CM, Rohrberg KS, van Tilburg CM, Nagasubramanian R, Berlin JD, Federman N, Mascarenhas L, Geoerger B, Dowlati A, Pappo AS, Bielack S, Doz F, McDermott R, Patel JD, Schilder RJ, Tahara M, Pfister SM, Witt O, Ladanyi M, Rudzinski ER, Nanda S, Childs BH, Laetsch TW, Hyman DM, Drilon A (2020) Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials. Lancet Oncol 21:531\u2013540. https:\/\/doi.org\/10.1016\/s1470-2045(19)30856-3","journal-title":"Lancet Oncol"},{"key":"4133_CR12","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI85271","volume":"126","author":"I Landa","year":"2016","unstructured":"Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, Dogan S, Ricarte-Filho JC, Krishnamoorthy GP, Xu B, Schultz N, Berger MF, Sander C, Taylor BS, Ghossein R, Ganly I, Fagin JA (2016) Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Investig 126:1052\u20131066. https:\/\/doi.org\/10.1172\/JCI85271","journal-title":"J Clin Investig"},{"key":"4133_CR13","doi-asserted-by":"publisher","first-page":"100180","DOI":"10.1016\/j.modpat.2023.100180","volume":"36","author":"SE Lee","year":"2023","unstructured":"Lee SE, Lee MS, Bang H, Kim MY, Choi YL, Oh YL (2023) NTRK fusion in a cohort of BRAF p. V600E wild-type papillary thyroid carcinomas. Mod Pathol 36:100180. https:\/\/doi.org\/10.1016\/j.modpat.2023.100180","journal-title":"Mod Pathol"},{"key":"4133_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s12022-020-09648-9","volume":"31","author":"YC Lee","year":"2020","unstructured":"Lee YC, Chen JY, Huang CJ, Chen HS, Yang AH, Hang JF (2020) Detection of NTRK1\/3 rearrangements in papillary thyroid carcinoma using immunohistochemistry, fluorescent in situ hybridization, and next-generation sequencing. Endocr Pathol 31:348\u2013358. https:\/\/doi.org\/10.1007\/s12022-020-09648-9","journal-title":"Endocr Pathol"},{"key":"4133_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/cncy.22522","volume":"130","author":"YC Lee","year":"2022","unstructured":"Lee YC, Hsu CY, Lai CR, Hang JF (2022) NTRK-rearranged papillary thyroid carcinoma demonstrates frequent subtle nuclear features and indeterminate cytologic diagnoses. Cancer Cytopathol 130:136\u2013143. https:\/\/doi.org\/10.1002\/cncy.22522","journal-title":"Cancer Cytopathol"},{"key":"4133_CR16","doi-asserted-by":"publisher","unstructured":"Macerola E, Proietti A, Poma AM, Vignali P, Sparavelli R, Ginori A, Basolo A, Elisei R, Santini F, Basolo F (2022) Limited accuracy of Pan-Trk immunohistochemistry screening for NTRK rearrangements in follicular-derived thyroid carcinoma. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/ijms23137470","DOI":"10.3390\/ijms23137470"},{"key":"4133_CR17","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1530\/ERC-19-0325","volume":"26","author":"F Panebianco","year":"2019","unstructured":"Panebianco F, Nikitski AV, Nikiforova MN, Kaya C, Yip L, Condello V, Wald AI, Nikiforov YE, Chiosea SI (2019) Characterization of thyroid cancer driven by known and novel ALK fusions. Endocr Relat Cancer 26:803\u2013814. https:\/\/doi.org\/10.1530\/ERC-19-0325","journal-title":"Endocr Relat Cancer"},{"key":"4133_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/ERC-14-0467","volume":"22","author":"G Park","year":"2015","unstructured":"Park G, Kim TH, Lee HO, Lim JA, Won JK, Min HS, Lee KE, Park DJ, Park YJ, Park WY (2015) Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer. Endocr Relat Cancer 22:55\u201363. https:\/\/doi.org\/10.1530\/ERC-14-0467","journal-title":"Endocr Relat Cancer"},{"key":"4133_CR19","doi-asserted-by":"publisher","first-page":"e2100442","DOI":"10.1200\/po.21.00442","volume":"6","author":"JC Park","year":"2022","unstructured":"Park JC, Ashok A, Liu C, Kang H (2022) Real-world experience of NTRK fusion-positive thyroid cancer. JCO Precis Oncol 6:e2100442. https:\/\/doi.org\/10.1200\/po.21.00442","journal-title":"JCO Precis Oncol"},{"key":"4133_CR20","doi-asserted-by":"publisher","unstructured":"Pekova B, Sykorova V, Mastnikova K, Vaclavikova E, Moravcova J, Vlcek P, Lastuvka P, Taudy M, Katra R, Bavor P, Kodetova D, Chovanec M, Drozenova J, Astl J, Hrabal P, Vcelak J, Bendlova B (2021) NTRK fusion genes in thyroid carcinomas: clinicopathological characteristics and their impacts on prognosis. Cancers 13. https:\/\/doi.org\/10.3390\/cancers13081932","DOI":"10.3390\/cancers13081932"},{"key":"4133_CR21","doi-asserted-by":"publisher","first-page":"e87170","DOI":"10.1371\/journal.pone.0087170","volume":"9","author":"G Perot","year":"2014","unstructured":"Perot G, Soubeyran I, Ribeiro A, Bonhomme B, Savagner F, Boutet-Bouzamondo N, Hostein I, Bonichon F, Godbert Y, Chibon F (2014) Identification of a recurrent STRN\/ALK fusion in thyroid carcinomas. PLoS One 9:e87170. https:\/\/doi.org\/10.1371\/journal.pone.0087170","journal-title":"PLoS One"},{"key":"4133_CR22","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s12105-021-01386-6","volume":"16","author":"M Saliba","year":"2022","unstructured":"Saliba M, Mohanty AS, Ho AL, Drilon A, Dogan S (2022) Secretory carcinoma of the thyroid in a 49-year-old man treated with larotrectinib: protracted clinical course of disease despite the high-grade histologic features. Head Neck Pathol 16:612\u2013620. https:\/\/doi.org\/10.1007\/s12105-021-01386-6","journal-title":"Head Neck Pathol"},{"key":"4133_CR23","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1245\/s10434-024-15500-9","volume":"31","author":"DW Scholfield","year":"2024","unstructured":"Scholfield DW, Fitzgerald CWR, Boe LA, Eagan A, Levyn H, Xu B, Tuttle RM, Fagin JA, Shaha AR, Shah JP, Wong RJ, Patel SG, Ghossein R, Ganly I (2024) Defining the genomic landscape of diffuse sclerosing papillary thyroid carcinoma: prognostic implications of RET fusions. Ann Surg Oncol 31:5525\u20135536. https:\/\/doi.org\/10.1245\/s10434-024-15500-9","journal-title":"Ann Surg Oncol"},{"key":"4133_CR24","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/pas.0000000000000814","volume":"41","author":"RR Seethala","year":"2017","unstructured":"Seethala RR, Chiosea SI, Liu CZ, Nikiforova M, Nikiforov YE (2017) Clinical and morphologic features of ETV6-NTRK3 translocated papillary thyroid carcinoma in an adult population without radiation exposure. Am J Surg Pathol 41:446\u2013457. https:\/\/doi.org\/10.1097\/pas.0000000000000814","journal-title":"Am J Surg Pathol"},{"key":"4133_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12022-024-09808-1","volume":"35","author":"KP Shih","year":"2024","unstructured":"Shih KP, Lee YC, Tsai JJ, Lin SH, Liu CY, Li WS, Li CF, Hang JF (2024) Clinicopathologic Features and Cytologic Correlation of ALK-rearranged papillary thyroid carcinoma: a series of eight cases. Endocr Pathol 35:134\u2013146. https:\/\/doi.org\/10.1007\/s12022-024-09808-1","journal-title":"Endocr Pathol"},{"key":"4133_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41698-023-00449-x","volume":"7","author":"A Shreenivas","year":"2023","unstructured":"Shreenivas A, Janku F, Gouda MA, Chen HZ, George B, Kato S, Kurzrock R (2023) ALK fusions in the pan-cancer setting: another tumor-agnostic target? NPJ Precis Oncol 7:101. https:\/\/doi.org\/10.1038\/s41698-023-00449-x","journal-title":"NPJ Precis Oncol"},{"key":"4133_CR27","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"The Cancer Genome Atlas Research Network","year":"2014","unstructured":"The Cancer Genome Atlas Research Network (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159:676\u2013690. https:\/\/doi.org\/10.1016\/j.cell.2014.09.050","journal-title":"Cell"},{"key":"4133_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.humpath.2024.06.004","volume":"149","author":"I TondiResta","year":"2024","unstructured":"TondiResta I, Rind A, Montone KT, Livolsi VA, Baloch ZW (2024) A comparison of the histopathologic features of thyroid carcinomas with NTRK fusions to those with other malignant fusions. Hum Pathol 149:29\u201338. https:\/\/doi.org\/10.1016\/j.humpath.2024.06.004","journal-title":"Hum Pathol"},{"key":"4133_CR29","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/cncy.22374","volume":"128","author":"K Viswanathan","year":"2020","unstructured":"Viswanathan K, Chu YH, Faquin WC, Sadow PM (2020) Cytomorphologic features of NTRK-rearranged thyroid carcinoma. Cancer Cytopathol 128:812\u2013827. https:\/\/doi.org\/10.1002\/cncy.22374","journal-title":"Cancer Cytopathol"},{"key":"4133_CR30","doi-asserted-by":"publisher","first-page":"154180","DOI":"10.1016\/j.prp.2022.154180","volume":"240","author":"HG Vuong","year":"2022","unstructured":"Vuong HG, Le HT, Le TTB, Le T, Hassell L, Kakudo K (2022) Clinicopathological significance of major fusion oncogenes in papillary thyroid carcinoma: an individual patient data meta-analysis. Pathol Res Pract 240:154180. https:\/\/doi.org\/10.1016\/j.prp.2022.154180","journal-title":"Pathol Res Pract"},{"key":"4133_CR31","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/his.14550","volume":"80","author":"B Xu","year":"2022","unstructured":"Xu B, David J, Dogan S, Landa I, Katabi N, Saliba M, Khimraj A, Sherman EJ, Tuttle RM, Tallini G, Ganly I, Fagin JA, Ghossein RA (2022) Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases. Histopathology 80:322\u2013337. https:\/\/doi.org\/10.1111\/his.14550","journal-title":"Histopathology"},{"key":"4133_CR32","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1089\/thy.2020.0086","volume":"30","author":"B Xu","year":"2020","unstructured":"Xu B, Fuchs T, Dogan S, Landa I, Katabi N, Fagin JA, Tuttle RM, Sherman E, Gill AJ, Ghossein R (2020) Dissecting anaplastic thyroid carcinoma: a comprehensive clinical, histologic, immunophenotypic, and molecular study of 360 cases. Thyroid 30:1505\u20131517. https:\/\/doi.org\/10.1089\/thy.2020.0086","journal-title":"Thyroid"},{"key":"4133_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/his.13981","volume":"76","author":"B Xu","year":"2020","unstructured":"Xu B, Haroon Al Rasheed MR, Antonescu CR, Alex D, Frosina D, Ghossein R, Jungbluth AA, Katabi N (2020) Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion. Histopathology 76:375\u2013382. https:\/\/doi.org\/10.1111\/his.13981","journal-title":"Histopathology"},{"key":"4133_CR34","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/his.14772","volume":"81","author":"B Xu","year":"2022","unstructured":"Xu B, Viswanathan K, Umrau K, Al-Ameri TAD, Dogan S, Magliocca K, Ghossein RA, Cipriani NA, Katabi N (2022) Secretory carcinoma of the salivary gland: a multi-institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors. Histopathology 81:670\u2013679. https:\/\/doi.org\/10.1111\/his.14772","journal-title":"Histopathology"},{"key":"4133_CR35","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm.4333","volume":"23","author":"A Zehir","year":"2017","unstructured":"Zehir A, Benayed R, Shah RH, Syed A, Middha S, Kim HR, Srinivasan P, Gao J, Chakravarty D, Devlin SM, Hellmann MD, Barron DA, Schram AM, Hameed M, Dogan S, Ross DS, Hechtman JF, DeLair DF, Yao J, Mandelker DL, Cheng DT, Chandramohan R, Mohanty AS, Ptashkin RN, Jayakumaran G, Prasad M, Syed MH, Rema AB, Liu ZY, Nafa K, Borsu L, Sadowska J, Casanova J, Bacares R, Kiecka IJ, Razumova A, Son JB, Stewart L, Baldi T, Mullaney KA, Al-Ahmadie H, Vakiani E, Abeshouse AA, Penson AV, Jonsson P, Camacho N, Chang MT, Won HH, Gross BE, Kundra R, Heins ZJ, Chen HW, Phillips S, Zhang H, Wang J, Ochoa A, Wills J, Eubank M, Thomas SB, Gardos SM, Reales DN, Galle J, Durany R, Cambria R, Abida W, Cercek A, Feldman DR, Gounder MM, Hakimi AA, Harding JJ, Iyer G, Janjigian YY, Jordan EJ, Kelly CM, Lowery MA, Morris LGT, Omuro AM, Raj N, Razavi P, Shoushtari AN, Shukla N, Soumerai TE, Varghese AM, Yaeger R, Coleman J, Bochner B, Riely GJ, Saltz LB, Scher HI, Sabbatini PJ, Robson ME, Klimstra DS, Taylor BS, Baselga J, Schultz N, Hyman DM, Arcila ME, Solit DB, Ladanyi M, Berger MF (2017) Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med 23:703\u2013713. https:\/\/doi.org\/10.1038\/nm.4333","journal-title":"Nat Med"},{"key":"4133_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.18632\/oncotarget.28555","volume":"15","author":"W Zhang","year":"2024","unstructured":"Zhang W, Schmitz AA, Kallionp\u00e4\u00e4 RE, Per\u00e4l\u00e4 M, Pitk\u00e4nen N, Tukiainen M, Alanne E, J\u00f6hrens K, Schulze-Rath R, Farahmand B, Zong J (2024) Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: a clinicogenomic biobank and record linkage study from Finland. Oncotarget 15:106\u2013116. https:\/\/doi.org\/10.18632\/oncotarget.28555","journal-title":"Oncotarget"},{"key":"4133_CR37","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41379-018-0175-7","volume":"32","author":"G Zhu","year":"2019","unstructured":"Zhu G, Benayed R, Ho C, Mullaney K, Sukhadia P, Rios K, Berry R, Rubin BP, Nafa K, Wang L, Klimstra DS, Ladanyi M, Hameed MR (2019) Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma. Mod Pathol 32:609\u2013620. https:\/\/doi.org\/10.1038\/s41379-018-0175-7","journal-title":"Mod Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04133-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04133-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04133-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T07:21:38Z","timestamp":1764055298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04133-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4133"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04133-2","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research is approved by the Institutional Review Board (IRB 17\u2013103).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to reproduce material from other sources"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}}]}}